Trials that use: Wald / z-test
2,196 results
- Cranial Electric Stimulation to Modify Suicide Risk Factors in Psychiatric Inpatients.: Complete Statistical AnalysisIndependent statistical analysis of Cranial Electric Stimulation to Modify Suicide Risk Factors in Psychiatric Inpatients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CRCIndependent statistical analysis of Optimal Dose of Combination of Rocuronium and Cisatracurium: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02495038).
- CREDO 2Independent statistical analysis of Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate…
- CriSP-HSIndependent statistical analysis of Cold Stored Platelet in Hemorrhagic Shock: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04667468).
- CRISTALLOIndependent statistical analysis of A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine And Rituximab (BR) in FIT…
- Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPD: Complete Statistical AnalysisIndependent statistical analysis of Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPD: primary endpoint results, effect estimate with…
- CROWN CORONAIndependent statistical analysis of CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04333732).
- CTRADIndependent statistical analysis of Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CTREPHIndependent statistical analysis of Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- CTS-1027 in Interferon-Naive Hepatitis C Patients: Complete Statistical AnalysisIndependent statistical analysis of CTS-1027 in Interferon-Naive Hepatitis C Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00925990).
- CTSI Pilot: Improving Adherence to Diabetic Diet: Complete Statistical AnalysisIndependent statistical analysis of CTSI Pilot: Improving Adherence to Diabetic Diet: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04051008).
- CURBIndependent statistical analysis of Cocaine Use Reduction With Buprenorphine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01402492).
- Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Curing Atrial Fibrillation in Heart Failure: Complete Statistical AnalysisIndependent statistical analysis of Curing Atrial Fibrillation in Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00292162).
- Curriculum Evaluation of a Novel Health and Wellness Program Within New York City Schools: Complete Statistical AnalysisIndependent statistical analysis of Curriculum Evaluation of a Novel Health and Wellness Program Within New York City Schools: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- CUTEXIndependent statistical analysis of Cold Urticaria Treatment With Xolair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01580592).
- Cystoinflation to Prevent Bladder Injury in Obstetrics and Gynaecology Surgery: Complete Statistical AnalysisIndependent statistical analysis of Cystoinflation to Prevent Bladder Injury in Obstetrics and Gynaecology Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04302545).
- D Mannose in Recurrent Urinary Tract Infections: Complete Statistical AnalysisIndependent statistical analysis of D Mannose in Recurrent Urinary Tract Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01808755).
- D-LUCSIndependent statistical analysis of Combined Pharmacotherapy for Cannabis Dependency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01020019).
- DAILIES TOTAL1® Lens Centration in a Japanese Population: Complete Statistical AnalysisIndependent statistical analysis of DAILIES TOTAL1® Lens Centration in a Japanese Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02252133).
- Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV: Complete Statistical AnalysisIndependent statistical analysis of Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- dal-GenEIndependent statistical analysis of Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DAR-PIAIndependent statistical analysis of DAR-901 TB Booster Vaccine to Prevent TB in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02712424).
- Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab: Complete Statistical AnalysisIndependent statistical analysis of Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis: Complete Statistical AnalysisIndependent statistical analysis of DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03825315).
- DAYBREAK-ALZIndependent statistical analysis of A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Daytime vs. Delayed Eating Among Obese Individuals: Complete Statistical AnalysisIndependent statistical analysis of Daytime vs. Delayed Eating Among Obese Individuals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03354169).
- DEARIndependent statistical analysis of Dose Escalation and Remission (DEAR): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00652145).
- DEBRAIndependent statistical analysis of Investigating the Causal Role of Prefrontal Control in Decision-making in Patients With Anhedonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Decision Support for Smoking Cessation in Young Adults With Severe Mental Illness: Complete Statistical AnalysisIndependent statistical analysis of Decision Support for Smoking Cessation in Young Adults With Severe Mental Illness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Decision-aid on Breast Cancer Screening: Complete Statistical AnalysisIndependent statistical analysis of Decision-aid on Breast Cancer Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03097653).
- Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS): Complete Statistical AnalysisIndependent statistical analysis of Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00903760).
- DEFEAT-AKIIndependent statistical analysis of Deferoxamine for the Prevention of Cardiac Surgery-Associated Acute Kidney Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04633889).
- DEFINEIndependent statistical analysis of Endophenotype for Alcohol Misuse in Healthy Minority Populations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00256451).
- DELISH R33Independent statistical analysis of (R33 Phase) DELISH Study: Diabetes Education to Lower Insulin, Sugars, and Hunger: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DELIVERIndependent statistical analysis of Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- DEP-CIIndependent statistical analysis of Combination Treatment Study for Memory Impairment and Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01658228).
- DEPICT 1Independent statistical analysis of Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02268214).
- Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion: Complete Statistical AnalysisIndependent statistical analysis of Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02061813).
- Design and Implementation of a Nutritional Intervention in Patients With Oropharyngeal Dysphagia: Complete Statistical AnalysisIndependent statistical analysis of Design and Implementation of a Nutritional Intervention in Patients With Oropharyngeal Dysphagia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Design and Testing of a Web-Based Tool for the Improvement of End-of-Life Planning in Patients With Advanced Cancer: Complete Statistical AnalysisIndependent statistical analysis of Design and Testing of a Web-Based Tool for the Improvement of End-of-Life Planning in Patients With Advanced Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Design Validation of Toric Contact Lenses in Senofilcon A With a Blue-Blocking Chromophore: Complete Statistical AnalysisIndependent statistical analysis of Design Validation of Toric Contact Lenses in Senofilcon A With a Blue-Blocking Chromophore: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Desmopressin Acetate 0.2 mg Tablets, Fasting: Complete Statistical AnalysisIndependent statistical analysis of Desmopressin Acetate 0.2 mg Tablets, Fasting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00835211).
- Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG: Complete Statistical AnalysisIndependent statistical analysis of Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Determination of the Duration of Action of a Lidocaine and a Bupivacaine Digital Nerve Block in Human Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Determination of the Duration of Action of a Lidocaine and a Bupivacaine Digital Nerve Block in Human Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- DeuceIndependent statistical analysis of Functional Performance of the Journey Deuce Bicompartmental Versus the Genesis II Total Knee System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Developing a Patient Navigation Intervention for PrEP Continuum of Care Among Young Latino MSM (PrEParate): Complete Statistical AnalysisIndependent statistical analysis of Developing a Patient Navigation Intervention for PrEP Continuum of Care Among Young Latino MSM (PrEParate): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Developing an Implementation Strategy for Post-concussion Communication With Low Health Literacy Parents in the Emergency Department: Complete Statistical AnalysisIndependent statistical analysis of Developing an Implementation Strategy for Post-concussion Communication With Low Health Literacy Parents in the Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Developing and Testing a Comprehensive MS Spasticity Management Program: Complete Statistical AnalysisIndependent statistical analysis of Developing and Testing a Comprehensive MS Spasticity Management Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02170779).